Numab's Pipeline To Benefit From Intarcia Licensing Its ND016

 
• By Sten Stovall
  
Nerve cells
Numab develops next-generation multispecific antibody-based immunotherapies • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business